VOCAL-EXT: Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis (clinicaltrials.gov) - Jun 18, 2025 - P3 | N=40 | Enrolling by invitation | Sponsor: Aurinia Pharmaceuticals Inc. | Trial completion date: Sep 2026 ➔ Jun 2029 | Trial primary completion date: Jun 2026 ➔ Dec 2028
Trial completion date • Trial primary completion date • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics
|